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Abstract We previously have shown that the overexpression of
phospholipase C-Q1 (PLC-Q1) in rat 3Y1 fibroblasts results in
malignant transformation (Chang, J.-S., Noh, D.Y., Park, I.A.,
Kim, M.J., Song, H., Ryu, S.H. and Suh, P.-G. (1997) Cancer
Res. 57, 5465^5468). The transformed cells, which initially are in
an elongated and flat form after seeding in plastic dishes, become
rounded during continued culture. We found that tyrosine
dephosphorylation of paxillin accompanies this morphological
change of the transformed cells and that PLC-Q1 co-immuno-
precipitates together with paxillin and vice versa, but not after
the cells have become round. Transformed cells growing on
fibronectin-pre-coated dishes regain their flat morphology and
this is accompanied by paxillin tyrosine phosphorylation.
Furthermore, immunoprecipitation analysis showed that paxillin
forms a heteromeric complex with PLC-Q1 in cells grown on
fibronectin. These results suggest that a complex formation
between paxillin and PLC-Q1 may play a role in cell-substrate
adhesion.
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1. Introduction
Phosphoinositide-speci¢c PLC-Q1 plays a critical role in cel-
lular signaling by triggering the formation of two second mes-
sengers, diacylglycerol and inositol 1,4,5-trisphosphate [1]. It
has also been revealed that PLC-Q1 functions in mitogenic
signaling [2,3] and cytoskeletal rearrangement [4^7]. Further-
more, it has recently been shown that overexpression of PLC-
Q1 can result in cellular transformation of rat 3Y1 cells [8] and
NIH 3T3 cells [9].
In order to gain a better understanding of the mechanism
underlying the PLC-Q1-mediated cell transformation, we ¢rst
examined the level of tyrosine phosphorylation on the cellular
proteins in transformed 3Y1 cells, because transformed cells
exhibit a di¡erent level of protein tyrosine phosphorylation in
comparison to wild-type. We unexpectedly found paxillin ty-
rosine to be dephosphorylated in PLC-Q1-transformed cells.
Paxillin is found enriched in focal adhesions, where discrete
areas of the cell membrane form links between the cytoskele-
ton and the extracellular matrix by coupling to integrin. Dur-
ing the assembly of focal adhesions, phosphorylated paxillin
acts as an adapter in the recruitment of signaling molecules
containing SH2 domains, such as p125 focal adhesion kinase
(FAK), Src, Csk, Crk, Grb-2, p130cas and PI-3 kinase [10].
PLC-Q1 binds to FAK [11] and has also been suggested to be
a focal adhesion protein [7,12]. Furthermore, it has been
shown recently that several protein tyrosine phosphatases
are involved in the dephosphorylation of FAK and paxillin
[13,14]. In this paper, we describe how tyrosine-phosphoryl-
ated paxillin associates with PLC-Q1, when transformed cells
adhered to the substrate, while there is no such association
after the cells have become rounded.
2. Materials and methods
2.1. Materials
The antibodies used were anti-human PLC-Q1 antibody (monoclo-
nal antibody F-7) [15], anti-phosphotyrosine antibody (PY20, Trans-
duction Laboratory) and anti-paxillin antibody (Z035, Zymed). Hy-
gromycin B was purchased from Calbiochem. Phenylmethylsulfonyl
£uoride, leupeptin, aprotinin and sodium orthovanadate were from
Sigma. Fibronectin (F4759), bovine serum albumin (BSA, A9418) and
poly-L-lysine (P6282) were from Sigma. The enhanced chemilumines-
cence detection system was purchased from Amersham.
2.2. Cell culture and adhesion to substrate
The rat embryonic ¢broblast 3Y1 cells, originally a gift from Dr
Kimura (Kyushu University, Fukuoka, Japan), the PLC-Q1-trans-
formed cells and the vector-transfected cells (control cells) were grown
in Dulbecco’s modi¢ed Eagle’s medium (DMEM, Life Technologies)
containing 10% bovine calf serum (HyClone). The two latter cell lines
were cultured in the presence of 50 Wg/ml hygromycin B [8]. The
assays of cell adhesion to various substrates were performed by pre-
coating 100 mm plastic culture dishes with 15 Wg/ml ¢bronectin,
50 Wg/ml poly-L-lysine or 1% BSA for 4 h at 37‡C, followed by washes
in phosphate-bu¡ered saline (PBS) and blocking with 1% BSA for 2 h.
Transformed cells on day 3^4 were trypsinized, washed twice with
PBS containing 0.5 mg/ml soybean trypsin inhibitor and resuspended
in DMEM without serum. Then, the cells were added to dishes pre-
coated with the various substrates and incubated at 37‡C in the ab-
sence of serum for 1 h. The cells were then washed and lysed and the
lysates were used for immunoprecipitation and immunoblot analysis
with appropriate antibodies.
2.3. Immunoblot analysis and immunoprecipitation
Cells cultured in 100 or 150 mm dishes (Falcon) were lysed in 500 Wl
of lysis bu¡er (10 mM HEPES-NaOH (pH 7.4), 200 mM NaCl, 2%
sodium dodecyl sulfate (SDS), 10 Wg/ml leupeptin, 5 Wg/ml aprotinin,
1 mM phenylmethylsulfonyl £uoride and 1 mM sodium orthovana-
date) and the extracts boiled for 3 min. The lysates were then soni-
cated for 10 s and centrifuged at 10 000Ug for 20 min. Constant
amounts of the cleared lysates (50^100 Wg protein per lane) were
subjected to 7.5 or 10% SDS-polyacrylamide gel electrophoresis
(PAGE) and immunoblot-analyzed as described previously [16]. For
immunoprecipitation, the cells were lysed in RIPA bu¡er containing
protease inhibitors [16]. Each extract (500^1000 Wg protein) was al-
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lowed to react with a pre-formed complex of Staphylococcus aureus
goat anti-mouse IgG (Pansorbin, Calbiochem) complex and either
pre-immune serum or anti-paxillin antibody. After a 12^14 h incuba-
tion at 4‡C, pellets were obtained by centrifugation at 6000Ug for
3 min, washed three times with RIPA bu¡er and boiled for 3 min.
Immunoblot analysis was carried out as described above, except that
it took 12^14 h of incubation with the anti-paxillin antibody to obtain
a good signal.
3. Results
3.1. Tyrosine dephosphorylation of paxillin in
PLC-Q1-transformed cells
Rat ¢broblasts 3Y1 subclones overexpressing PLC-Q1 ex-
hibit a transformed phenotype which includes anchoring-in-
dependent growth in culture dishes and tumor formation in
nude mice [8]. In Petri dishes, these clones take on an elon-
gated morphology after seeding. The cells maintain this form
when the medium is replaced every 2 days with fresh medium
and serum (Fig. 1A, b and c). If the medium is not changed,
however, the cells become round on day 3^4 (Fig. 1A, e and
f). If the cells are cultured in the absence of serum, they
become round within 20 h (data not shown). In order to
identify the pattern of total cellular protein tyrosine phos-
phorylation that parallels the above morphological changes,
we immuno-analyzed blots of the whole cell lysates with anti-
phosphotyrosine antibody. Unexpectedly, the transformed
cells showed bands of 65^70 kDa protein species whose tyro-
sine phosphorylation seemed depressed in comparison to con-
trol cells (Fig. 1B).
Fig. 1. Morphological alteration and paxillin tyrosine dephosphorylation in PLC-Q1-transformed cells. (A) Control, vector-transfected 3Y1 cells
(a and d) and PLC-Q1-transformed cells #145-20 (b and e) and #145-21 (c and f) were plated at a density of 5U106 cells per 100 mm dish.
Photographs were taken on day 2 (a, b and c) and day 4 (d, e and f) without change of medium. In contrast to the quiescent phase of the con-
trol cells (d), PLC-Q1-transformed cells (e and f) exhibit a proliferative stage on day 4. (B) Whole cell lysates of vector-transfected cells and
PLC-Q1-transformed cells (# 145-20 and -21) were prepared and aliquots of 50 Wg protein of each lysate were resolved by 10% SDS-PAGE and
transferred to a nitrocellulose ¢lter for immunoblot analysis with anti-PLC-Q1 antibody (a) and anti-phosphotyrosine antibody, PY20 (b).
(C) Vector-transfected control, #145-20 and #145-21 cells were cultured for 3 days, lysed in RIPA bu¡er and proteins were immunoprecipitated
with anti-paxillin antibody. The immuno-complexes were resolved by 10% SDS-PAGE, blotted and analyzed with anti-phosphotyrosine anti-
body (upper) and anti-paxillin antibody (lower).
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Paxillin, a well known focal adhesion protein, comprises
a family of proteins with molecular masses around 65^
70 kDa, which are substrates for tyrosine kinases such as
p125FAK, p60src and Csk [17,18] and also serine/
threonine kinases [19]. We therefore examined whether
these proteins were paxillins. Fig. 1C shows that a major
band could be recovered by immunoprecipitation with
anti-paxillin antibody and that it was tyrosine-dephosphoryl-
ated in transformed cells but not in control cells. We also
detected only little paxillin in immunoprecipitates with anti-
phosphotyrosine antibody of transformed cells, while there
were plenty paxillin molecules in control cells (data not
shown). We thus concluded that the tyrosine-dephosphoryl-
ated 65^70 kDa protein in the transformed cells is indeed
paxillin.
3.2. Correlation between paxillin tyrosine dephosphorylation
and cell morphology
As mentioned above, PLC-Q1-transformed 3Y1 cells be-
come rounded if the medium is not changed in a timely man-
ner. We looked, therefore, for a relationship between the
morphological alteration and the level of tyrosine dephos-
phorylation on paxillin using various substrates. Since ¢bro-
nectin and poly-L-lysine are well known to provide extracel-
lular matrices for cell adhesion, we pre-coated plastic dishes
with ¢bronectin, poly-L-lysine or BSA, which is a control for
suspension culture. We then seeded round cells immediately
after trypsinization into the prepared dishes. As shown in Fig.
2A, the cells on ¢bronectin (b) and poly-L-lysine (d) were £at
within 1 h, while those on BSA (c) were not. Although both,
the cells in the ¢bronectin and those in the poly-L-lysine-pre-
Fig. 2. Fibronectin restores paxillin tyrosine dephosphorylation and £attening of the cells. (A) Images of cells adhering to various substrates.
PLC-Q1-transformed cells on day 3 (a) were collected immediately after trypsinization. The cells were then transferred for 1 h onto ¢bronectin-
(b), BSA- (c) and poly-L-lysine- (d) pre-coated dishes without serum. (B) Tyrosine phosphorylation of paxillin was determined for extracts of
the above cells after trypsinization (SUS) and of cells adhering to the substrate by immunoprecipitation of paxillin followed by anti-phospho-
tyrosine (left) and anti-paxillin (right) immunoprobing. WCL stands for whole cell lysate. The bars on the left of the panel represent molecular
weight (MW) markers of 220, 117, 78 and 46 kDa, respectively.
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coated dishes, adhered to the substrate tightly, the cells adher-
ing to the ¢bronectin-pre-coated dish were much £atter in
form. On the other hand, the cells in the BSA-pre-coated
dish did not attach to the substrate, i.e. stayed in suspension,
for up to 1 h. We extracted total protein from cells cultured
under the above conditions and immunoprecipitated paxillin
using anti-paxillin antibody. We then followed up by immu-
noblot analysis with anti-phosphotyrosine antibody (Fig. 2B).
The cells that had attached to the ¢bronectin- or poly-L-ly-
sine-pre-coated dishes showed restored tyrosine phosphoryla-
tion of paxillin. This result demonstrates that paxillin tyrosine
dephosphorylation went hand in hand with the round mor-
phology of the transformed cells. Paxillin is a major intra-
cellular protein that exists in three isomers (K, L and Q) and
exhibits heterogeneity in the phosphorylation on serine, threo-
nine and tyrosine residues [18,20], which explains the several
bands seen on the anti-phosphotyrosine immunoblot (Fig.
2B).
3.3. Paxillin co-immunoprecipitates with PLC-Q1
Since many signaling molecules are associated with paxillin
[10,11], we examined the possibility that the extra amounts of
the overexpressed PLC-Q1 might bind paxillin in the trans-
formed cells. Using cell extracts prepared exactly the same
way as those shown in Fig. 2, we precipitated PLC-Q1 with
anti-PLC-Q1 antibody. We found that paxillin co-immunopre-
cipitated with PLC-Q1 from cell extracts of cells grown on the
¢bronectin- or poly-L-lysine-pre-coated dishes (Fig. 3A). The
amount of paxillin which co-precipitated with PLC-Q1 was
calculated as 0.5% of total paxillin for ¢bronectin- and 0.1%
of total paxillin for poly-L-lysine-attached cells by an image
analysis system (Quantity One, Bio-Rad). No such precipita-
tion of paxillin was obtained from extracts of cells recovered
from BSA-pre-coated dishes or from any round cells.
Alternatively, we also plated transformed cells in medium
containing 10% bovine calf serum and we prepared cell ex-
tracts in a time-course. Paxillin was then immunoprecipitated
Fig. 3. PLC-Q1 co-immunoprecipitates with paxillin. (A) Cell extracts prepared exactly the same way as those in Fig. 2B were subjected to im-
munoprecipitation of PLC-Q1 with anti-PLC-Q1 antibody and analyzed by anti-paxillin (left) and anti-PLC-Q1 (right) immunoblot analysis.
WCL and Dish indicate whole cell lysate and plastic cell culture dish, respectively. The bars on the left represent MW markers of 220, 117, 78
and 46 kDa, respectively. (B) PLC-Q1-transformed cells (#145-20) were cultured and harvested at di¡erent time intervals. The cell extracts were
used for paxillin immunoprecipitation with anti-paxillin antibody. The immunoprecipitates were resolved by 7.5% SDS-PAGE and analyzed
with anti-phosphotyrosine antibody (PY20, upper panel), anti-paxillin antibody (middle panel) and anti-PLC-Q1 antibody (lower panel). NRS
stands for normal rabbit serum.
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from each extract and subjected to immunoblot analysis with
anti-phosphotyrosine antibody. As was observed before, the
tyrosine phosphorylation level of paxillin decreased from day
1 to day 4 (Fig. 3B). We also immuno-detected PLC-Q1 in the
paxillin immunoprecipitate of day 2 (elongated form), but
only little on day 4 (round form) (Fig. 3B). The results, there-
fore, indicate that those two proteins exist in a complex before
the cells round-up.
4. Discussion
Our present study revealed that the rounding morphology
of PLC-Q1-transformed rat 3Y1 ¢broblasts is accompanied by
tyrosine dephosphorylation of paxillin. The observations
made by us di¡er from those described in reports of transient
tyrosine dephosphorylation of paxillin induced by extracellu-
lar ligands such as insulin and insulin-like growth factor
[13,21,22], cAMP [23] and adrenocorticotropic hormone [24].
The two latter cases are also accompanied by transient mor-
phological alterations. With regard to the relationship be-
tween cell morphology and paxillin tyrosine dephosphoryla-
tion, we observed contradictory results regarding the rounding
of cells. While we saw heavy tyrosine phosphorylation of pax-
illin in v-src-transformed 3Y1 cells, we saw tyrosine dephos-
phorylation of paxillin in mitotic 3Y1 cells (data not shown)
[17,25,26]. These observations, therefore, suggest that the pax-
illin tyrosine dephosphorylation in PLC-Q1-transformed cells
is not a transformation-speci¢c phenomenon.
The question remains as to which molecule is responsible
for the dephosphorylation of paxillin in the PLC-Q1-trans-
formed 3Y1 cells. Although the precise role played by protein
tyrosine phosphatases in focal adhesion has not yet been con-
clusively established, several protein tyrosine phosphatases
such as PTP-1D [13], PTP-PEST [14], Sph-2 [27] and PTP-
1B [28] have been shown to dephosphorylate adhesion mole-
cules. We also found that pervanadate, a tyrosine phosphatase
inhibitor, a¡ects the cell morphology causing cells to become
£atter (data not shown). Therefore, it is possible to speculate
that cells overexpressing PLC-Q1 experience some protein ty-
rosine phosphatase activation that a¡ects tyrosine phospho-
rylation of paxillin, resulting in less tyrosine-phosphorylated
paxillin.
Alternatively, since it has been shown that the serine/threo-
nine phosphorylation of paxillin enhances translocation of
paxillin to focal adhesions, increasing the ability of cells to
adhere to the substrate [19], we cannot exclude the possibility
that PLC-Q1 a¡ects serine/threonine kinase activity in trans-
formed cells. In any way, it is certain that ectopically ex-
pressed PLC-Q1 modi¢es the phosphorylation and dephos-
phorylation of adhesion molecules, which activity may be an
important factor in facilitating cell spreading and cell motility.
Our present data also show paxillin/PLC-Q1 association in
PLC-Q1-transformed cells. Although the amount of associated
protein (PLC-Q1 co-immunoprecipitate with paxillin or vice
versa) is restricted, it is meaningful to consider that PLC-Q1
might be involved in cell adhesion. To test whether the asso-
ciation is a direct one, we used a glutathione S-transferase-
fused SH2 domain of PLC-Q1 in vitro. However, the amount
of paxillin associated with the SH2 domain in vitro was ex-
tremely small and thus too low to support the notion that
paxillin might bind to PLC-Q1 directly. We, therefore, suggest
that the paxillin/PLC-Q1 complex formation during cell adhe-
sion might be mediated by other adhesion molecules such as
perhaps p125FAK [11,29].
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